These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 32669065)

  • 1. Higher venlafaxine serum concentrations necessary for clinical improvement? Time to re-evaluate the therapeutic reference range of venlafaxine.
    Scherf-Clavel M; Hommers L; Wurst C; Stonawski S; Deckert J; Domschke K; Unterecker S; Menke A
    J Psychopharmacol; 2020 Oct; 34(10):1105-1111. PubMed ID: 32669065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of venlafaxine in treatment responders and non-responders: a retrospective analysis of a large naturalistic database.
    Schoretsanitis G; Haen E; Gründer G; Hiemke C; Endres K; Ridders F; Correll CU; Paulzen M
    Eur J Clin Pharmacol; 2019 Aug; 75(8):1109-1116. PubMed ID: 30968172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venlafaxine induced QTc interval prolongation in a therapeutic dose.
    Bavle A
    Asian J Psychiatr; 2015 Aug; 16():63-4. PubMed ID: 26187237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of ABCB1 polymorphisms and serum concentrations on venlafaxine response in patients with major depressive disorder.
    Ozbey G; Celikel FC; Cumurcu BE; Kan D; Yucel B; Hasbek E; Percin F; Guzey IC; Uluoglu C
    Nord J Psychiatry; 2017 Apr; 71(3):230-237. PubMed ID: 28079463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venlafaxine ER Blocks the Norepinephrine Transporter in the Brain of Patients with Major Depressive Disorder: a PET Study Using [18F]FMeNER-D2.
    Arakawa R; Stenkrona P; Takano A; Svensson J; Andersson M; Nag S; Asami Y; Hirano Y; Halldin C; Lundberg J
    Int J Neuropsychopharmacol; 2019 Apr; 22(4):278-285. PubMed ID: 30649319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Bioavailability of Single-Dose Extended-Release Venlafaxine Capsules in Obese Patients Before and After Gastric Bypass Surgery.
    Krieger CA; Cunningham JL; Reid JM; Langman LJ; Grothe KB; Clark MM; Dierkhising RA
    Pharmacotherapy; 2017 Nov; 37(11):1374-1382. PubMed ID: 28845898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of antidepressant response to venlafaxine by a combination of early response assessment and therapeutic drug monitoring.
    Stamm TJ; Becker D; Sondergeld LM; Wiethoff K; Hiemke C; O'Malley G; Ricken R; Bauer M; Adli M
    Pharmacopsychiatry; 2014 Jul; 47(4-5):174-9. PubMed ID: 25054625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension and orthostatic hypotension with venlafaxine treatment in depressed older adults.
    Wathra R; Mulsant BH; Thomson L; Goldberger KW; Lenze EJ; Karp JF; Sanches M; Reynolds CF; Blumberger DM
    J Psychopharmacol; 2020 Oct; 34(10):1112-1118. PubMed ID: 32842836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the pharmacokinetic interaction between ticagrelor and venlafaxine, a cytochrome P-450 2D6 substrate, in healthy subjects.
    Teng R; Kujacic M; Hsia J
    Clin Ther; 2014 Sep; 36(9):1217-25. PubMed ID: 25069798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine.
    Maneeton N; Maneeton B; Eurviriyanukul K; Srisurapanont M
    Drug Des Devel Ther; 2013; 7():1053-62. PubMed ID: 24101861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of the efficacy of venlafaxine extended release 75-225 mg/day for the treatment of major depressive disorder.
    Thase M; Asami Y; Wajsbrot D; Dorries K; Boucher M; Pappadopulos E
    Curr Med Res Opin; 2017 Feb; 33(2):317-326. PubMed ID: 27794623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seizure Induced by a Therapeutic Dose of Venlafaxine ER: A Case Report.
    Ye C; Ninneman M; Christian JS; Zhang F; Musselman D
    J Psychiatr Pract; 2018 Mar; 24(2):117-120. PubMed ID: 29509182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of the effectiveness of an early medication change strategy in patients with major depressive disorder.
    Dreimüller N; Wagner S; Engel A; Braus DF; Roll SC; Elsner S; Tadić A; Lieb K
    BMC Psychiatry; 2019 Jan; 19(1):24. PubMed ID: 30642308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duloxetine in elderly major depression disorder: effectiveness and drug plasma level evaluation.
    Rovera C; Mauri MC; Bertin E; Di Pace C; Paletta S; Reggiori A; De Gaspari IF; Cattaneo D; Mari D; Altamura AC
    Hum Psychopharmacol; 2016 Sep; 31(5):349-55. PubMed ID: 27400882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Items Predicting Non-Remission after 6 Months of Treatment of Patients with Generalized Anxiety Disorder Covered the Eysenck Neuroticism Components of Anxiety, Interpersonal Sensitivity and Depression.
    Bech P; Rickels K
    Psychother Psychosom; 2016; 85(4):229-30. PubMed ID: 27230864
    [No Abstract]   [Full Text] [Related]  

  • 18. The Effect of Venlafaxine on Electrocardiogram Intervals During Treatment for Depression in Older Adults.
    Behlke LM; Lenze EJ; Pham V; Miller JP; Smith TW; Saade Y; Karp JF; Reynolds CF; Blumberger DM; Stefan C; Mulsant BH
    J Clin Psychopharmacol; 2020; 40(6):553-559. PubMed ID: 33044352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response.
    Perugi G; Frare F; Toni C; Ruffolo G; Torti C
    Neuropsychobiology; 2002; 46(3):145-9. PubMed ID: 12422062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.